London, United Kingdom
Scarlet, founded in 2020, is positioned uniquely in the healthcare sector as Europe’s only Notified Body specialised in software and AI. Headquartered in the United Kingdom, the company plays a crucial role in certifying software medical devices, focusing on the rapidly growing domain of Software as a Medical Device (SaMD).
The company is dedicated to accelerating the transition to accessible, affordable healthcare. By enabling clients to achieve certification for their life-saving technologies in the EU and UK, Scarlet ensures that patients have access to the most up-to-date software-driven medical solutions.
Strategically accredited, Scarlet is recognized as an EU Notified Body under Regulation (EU) 2017/745 (EU MDR) and a UK Approved Body, also authorized to issue ISO 13485 certificates. This strong regulatory foothold underscores its market strength.
Its most recent funding came from a £6M Seed Round on 30 August 2022, with support from notable investors Kindred Capital and Creandum, highlighting confidence in its vision and specialized market presence.
